For nearly four decades, cancer researchers faced a persistent problem. They knew that a mutation in a gene called KRAS was driving some of the deadliest tumors for pancreatic, lung, and colorectal cancers, but every attempt to build a drug that could block it came up short.
Similar Posts
Understanding Product Expiry: How Everyday Items Can Change Over Time
Most of us pay attention to expiry dates on food or medicine, but many people overlook…
A Successful Weight Loss Diet Starts from the Inside
Spread the love When it comes to weight loss, most of us are led to believe…
Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers
Just a couple of months after launching a partnership with direct-to-consumer telehealth company Hims & Hers,…
I Finally Found A Shoe That Can Actually Go From Squats To Sprints
The most significant change is an extra 1mm of stack height in both the heel and…
Pharmacogenomics Can Ease Burden On Doctors Treating Patients With Rare Diseases
During the pandemic, physician burnout rates skyrocketed to 62.8% in 2021. Since, those numbers have dropped…
WellTheory Introduces Autoimmune Postpartum Program
About 50 million people in the U.S. are affected by autoimmune disease, and about 80% of…
